Active transforming growth factor-β in human melanoma cell lines: No evidence for plasmin-related activation of latent TGF-β

Journal of Cellular Biochemistry

Volumn 62, Issue 1, 1996, Pages 113-122

  Bizik, Jozef ^a,b   Felnerova, Diana ^a   Grofova, Marta ^a   Vaheri, Antti ^b  

^a CANCER RESEARCH INSTITUTE   (Slovakia)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

activation; melanoma; transforming growth factor

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DNA DETERMINATION; DNA SYNTHESIS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MELANOMA; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS;

CULTURE MEDIA, CONDITIONED; DNA REPLICATION; HEAT; HUMANS; MELANOMA; PLASMIN; PLASMINOGEN; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0029847972     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(199607)62:1<113::AID-JCB12>3.0.CO;2-O     Document Type: Article

References (42)

1. Albino AP, Davis BM, Nanus DM (1991): Induction of growth factor-RNA expression in human malignant melanoma: Markers of transformation. Cancer Res 51:4815-4820.
2. Antonelli-Orlidge A, Saunders KB, Smith SR, D'Amore PA (1989): An activated form of transforming growth factor β is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci U S A 86:4544-4548.
3. Bizik J, Vaheri A, Saksela O, Kalkkinen N, Meri S, Grofova M (1986): Human tumor cells synthesize and secrete α-2-macroglobulin in vitro. Int J Cancer 37:81-88.
4. Bizik J, Lizonova A, Grofova M, Matoska J, Dore JF, Bertrand S, Blasko M, Vaheri A (1989): Clonal variation in the production of tumor-associated α-2-macroglobulin in a malignant human melanoma and association with growth stimulation. Cancer Res 49:983-990.
5. α2-macroglobulin secretion. Cell Regul 1:895-905.
6. Bizik J, Stephens RW, Grofova M, Vaheri A (1993): Binding of tissue-type plasminogen activator to human melanoma cells. J Cell Biochem 51:326-335.
7. Bodmer S, Strommer K, Frei K, Siepl C, De Tribolet N, Heid I, Fontana A (1989): Immunosuppression and transforming growth factor-β in glioblastoma. Preferential production of transforming growth factor-β2. J Immunol 10: 3222-3229.
8. Borth W (1992): α2-Macroglobulin, a multifunctional binding protein with targeting characteristics. FASEB J 6:3345-3353.
9. Brown PD, Wakefield LM, Levinson AD, Sporn MB (1990): Physicochemical activation of recombinant latent transforming growth factor-β's 1, 2 and 3. Growth Factors 3:35-43.
10. 2-macroglobulin. J Biol Chem 265:6973-6977.
11. De Vries TJ, Quax PHA, Denijn M, Verrijp KN, Verheijen JH, Verspaget HW, Weidle UH, Ruiter DJ, Van Muijen GNP (1994): Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression. Am J Pathol 144:70-81.
12. Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, Roberts AB, Sporn MB, Goeddel DV (1985): Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 316:701-705.
13. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, Berger WH (1987): Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res 47:707-712.
14. 2 in cultured keratinocytes and mouse epidermis. Cell Regul 1:87-97.
15. Grotendorst GR, Smalec G, Pencev D (1989): Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils. J Cell Physiol 140:396-402.
16. Hoal Van Helden EG, Wilson EL, Dowdle EB (1986): Characterization of seven human melanoma cell lines: Melanogenesis and secretion of plasminogen activators. Br J Cancer 54:287-295.
17. Huber D, Fontana A, Bodmer S (1991): Activation of human platelet-derived latent transforming growth factor-β1 by human glioblastoma cells. Biochem J 277:165-173.
18. Ikeda T, Lioubin MN, Marquardt H (1987): Human transforming growth factor type β2: Production by a prostatic adenocarcinoma cell line, purification and initial characterization. Biochemistry 26:2406-2410.
19. Jakubovich R, Cabrillat H, Gerlier D, Bailey M, Doré JF (1985): Tumorigenic phenotypes of human melanoma cell lines in nude mice determined by an active antitumor mechanism. Br J Cancer 51:335-345.
20. Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R, Dickson RB (1987): Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48:417-428.
21. Lahm H, Odartchenko N (1993): Role of transforming growth factor ßin colorectal cancer. Growth Factors 9:1-9.
22. Laiho M, Keski-Oja J (1989): Growth factors in the regulation of pericellular proteolysis: A review. Cancer Res 49: 2533-2553.
23. Lizonova A, Bizik J, Grofova M, Vaheri A (1990): Coexpression of tumor-associated α-2-macroglobulin and growth factors in human melanoma cell lines. J Cell Biochem 43:315-325.
24. Lyons RM, Keski-Oja J, Moses HL (1988): Proteolyticactiva-tion of latent transforming growth factor-ßfrom fibroblast-conditioned medium. J Cell Biol 106:1659-1665.
25. Lyons RM, Gentry LE, Purchio AF, Moses HL (1990): Mechanism of activation of latent recombinant transforming growth factor β1 by plasmin. J Cell Biol 110:1361-1367.
26. Lyons RM, Moses HL (1990): Transforming growth factors and the regulation of cell proliferation. Eur J Biochem 187:467-473.
27. MacDougall JR, Kobayashi H, Kerbel RS (1993): Responsiveness of normal, dysplastic melanocytes, and melanoma cells from different lesional stages of disease progression to the growth inhibitory effects of TGF-β. Mol Cell Differ 1:21-40.
28. Massagué J (1990): The transforming growth factor-β family. Annu Rev Cell Biol 6:597-641.
29. Massagué J (1992): Receptors for TGF-β family. Cell 69: 1067-1070.
30. Miyazono K, Hellman U, Wernstedt C, Heldin CH (1988): Latent high molecular weight complex of transforming growth factor β1. Purification from human platelets and structural characterization. J Biol Chem 263:6407-6415.
31. Miyazono K, Heldin CH (1989): Role for carbohydrate structures in TGF-β1 latency. Nature 338:158-160.
32. Neuman T, Stephens RW, Salonen EM, Timmusk T, Vaheri A (1989): Induction of morphological differentiation of human neuroblastoma cells is accompanied by induction of tissue-type plasminogen activator. J Neurosci Res 23: 274-281.
33. 2-macroglobulin. J Biol Chem 262:14090-14099.
34. Pircher R, Jullien P, Lawrence DA (1986): β-transforming growth factor is stored in human blood platelets as a latent high molecular weight complex. Biochem Biophys Res Commun 136:30-37.
35. Roberts AB, Sporn MB (1990): The transforming growth factor-β. In Sporn MB, Roberts AB (eds): "Handbook of Experimental Pharmacology: Peptide Growth Factors and Their Receptors." Vol 95. Heidelberg, Germany: Springer Verlag, pp 419-472.
36. Roberts AB, Anzano MA, Wakefield LM, Roche NS, Stern DF, Sporn MB (1985): Type-β transforming growth factor: A bifunctional regulator of cellular growth. Proc Natl Acad Sci U S A 82:119-123.
37. Rodeck U, Melber K, Kath R, Menssen HD, Varello M, Atkinson B, Herlyn M (1991): Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes. J Invest Dermatol 97:20-26.
38. Rodeck U, Bossier A, Graeven U, Fox FE, Nowell PC, Knabbe C, Kari C (1994): Transforming growth factor β production and responsiveness in normal human melanocytes and melanoma cells. Cancer Res 54:575-581.
39. Siracky J, Blasko M, Borovansky J, Kovarik J, Svec J, Vrba M (1982): Human melanoma cell lines: morphology, growth and α-mannosidase characteristics. Neoplasma 29: 661-668.
40. Stephens RW, Leung KC, Pöllänen J, Salonen EM, Vaheri A (1987): Microplate immunocapture assay for plasminogen activators and their inhibitors. J Immunol Methods 105: 245-251.
41. Vaheri A, Bizik J, Salonen EM, Tapiovaara H, Siren V, Myöhänen H, Stephens RW (1992): Regulation of the pericellular activation of plasminogen and its role in tissue-destructive processes. Acta Ophthalmoi Suppl 202:34-41.
42. Wakefield LM, Smith DM, Masui T, Harris CC, Sporn MB (1987): Distribution and modulation of the cellular receptor for transforming growth factor-beta. J Cell Biol 105: 967-975.